SCHEMBL6284284

SCHEMBL6284284

N=C(N)N/N=C(\c1cn(S(=O)(=O)c2ccc3ccccc3c2)c2ccc(Cl)cc12)C1CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 12/20 0.41
DRD2 P14416 3/20 0.36
HTR2A P28223 3/20 0.36
HTR7 P34969 3/20 0.36
HTR1A P08908 1/20 0.36
EIF2AK3 Q9NZJ5 1/20 0.36
TNFSF11 O14788 2/20 0.35
PPARG P37231 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
SLC6A2 P23975 1/20 0.35
HTR2C P28335 1/20 0.35
SLC6A4 P31645 1/20 0.35
HRH1 P35367 1/20 0.35
ADRA1B P35368 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KCNH2 Q12809 1/20 0.35
AKR1C3 P42330 2/20 0.35
AKR1C1 Q04828 1/20 0.35
TNF P01375 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6284287 1.00 HTR6 (0.41) HTR6DRD2HTR2AHTR7HTR1A
SCHEMBL6278624 0.90 HTR6 (0.44) HTR6HTR2AHTR7HTR1AAKR1C3
SCHEMBL6281981 0.90 TNFSF11 (0.44) HTR6DRD2HTR2AHTR7EIF2AK3
SCHEMBL6281979 0.90 TNFSF11 (0.44) HTR6DRD2HTR2AHTR7EIF2AK3
SCHEMBL6278622 0.90 HTR6 (0.44) HTR6HTR2AHTR7HTR1AAKR1C3
SCHEMBL6278481 0.86 HTR6 (0.42) HTR6DRD2HTR2AHTR7PPARG
SCHEMBL6278478 0.86 HTR6 (0.42) HTR6DRD2HTR2AHTR7PPARG
SCHEMBL6286694 0.86 HTR6 (0.46) HTR6DRD2HTR2AHTR7HTR1A
SCHEMBL6286697 0.86 HTR6 (0.46) HTR6DRD2HTR2AHTR7HTR1A
SCHEMBL6287714 0.86 HTR6 (0.43) HTR6DRD2HTR2AHTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6906095-B2 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2005-06-14 US disclosed
US-20040002527-A1 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands WYETH 2004-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002527-A1 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, HTR2A HTR6 1/4885DRD2 190/4885HTR2A 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.